A 24-week study to evaluate the efficacy and safety of once-weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD-8).

K M Dungan, Raimund Weitgasser (Co-author), F Perez Manghi, E Pintilei, J L Fahrbach, H H Jiang, J Shell, K E Robertson

Research output: Contribution to journalOriginal Articlepeer-review

73 Citations (Web of Science)
Original languageEnglish
Pages (from-to)475-482
JournalDIABETES OBESITY & METABOLISM
Volume18
Issue number5
DOIs
Publication statusPublished - 2016

Keywords

  • OPEN-LABEL TRIAL
  • TREATED PATIENTS
  • GLYCEMIC CONTROL
  • NON-INFERIORITY
  • PARALLEL-GROUP
  • LIRAGLUTIDE
  • METFORMIN
  • MELLITUS
  • ASSOCIATION
  • EXENATIDE

Cite this